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Thyroid operations are increasingly performed in the outpatient setting. In general the essential objec-
tives for thyroidectomy are: sparing the parathyroid glands, avoidance of injury to the laryngeal nerves,
an accurate hemostasis and an excellent cosmesis. In the last 10 years major improvements and new
technologies have been proposed and applied in thyroid surgery; among these mini-invasive thyroid-
ectomy, new devices for achieving hemostasis and dissection, intraoperative neuromonitoring, and PTH
assay technology. This paper reviews relevant medical literature published on the inﬂuence of these new
technologies on quality of thyroid surgery as well as prevention of postoperative morbidity and
mortality. Searches were last updated April 2008.
 2008 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
New technologies have been proposed and applied in thyroid
surgery. For example the mini-invasive video-assisted thyroidec-
tomy proposed and developed by Bellantone and Miccoli.1 The
intraoperative monitoring of laryngeal nerves in patients under-
going thyroid surgery is a fascinating new technique.2
In general the essential objectives for thyroidectomyare: sparing
the parathyroid glands, avoidance of injury to recurrent laryngeal
nerves (RLN), an accurate hemostasis and an excellent cosmesis.3
This paper reviews relevant medical literature published on the
inﬂuence of these new technologies on quality of thyroid surgery
performed with short hospitalization. Searches were last updated
August 2008.2. Prevention of bleeding
Hemostasis in thyroid surgery is achieved by means of the
conventional clamp-and-tie technique, diathermy, hemostatic
clips, and recently, by ultrasonic coagulating-dissection (HS) and
electrothermal bipolar vessel sealing systems (EBVSS).arch Center, Department of
rri, 57, 21100 Varese, Italy.
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ciates Ltd. Published by Elsevier Lt2.1. Ultrasonic coagulating-dissection system
(Ethicon endo-surgery, Cincinnati, OH, USA)
Voutilainem ﬁrst demonstrated that HS is a usable and safe
device in all thyroid procedures for cutting and coagulating tissue
with a signiﬁcant reduction of operating time, hospital stay, intra-
operative and postoperative bleeding.4 The mean operative time
using HS was an average of 10– 35% less than that required by
conventional methods.4 Takami demonstrated the use of the device
during total thyroidectomies in treatment of Graves’ disease; both
intraoperative and postoperative blood loss were reduced signiﬁ-
cantly by using HS.5 The author concluded that HS is safe for
treating hyperthyroidism, which could cause more problems with
hemostasis due to the high degree of vascularization of the gland.
Miccoli ﬁrst reported impressions with use of the HS (CS-14C
instrument) in endoscopic thyroidectomy.6 The use of HS for
endoscopic thyroidectomy was safe with a shorter operative time
and hospital stay. Meurisse demonstrated a reduction of post-
operative complications as the incidence of transient hypopara-
thyroidism, yet a better postoperative analgesia with a reduction of
analgesics by using HS.7 The explanation is that the device causes
lower tissue injury, surrounding thermal injury and no neuro-
muscular stimulation than traditional bipolar/monopolar instru-
ments.8 Moreover, less traction, minor manipulation of thyroid
tissues (in transecting the superior and inferior pole of the thyroid
artery and vein), thus reducing postoperative edema and inﬂam-
mation, are required using HS.8d. All rights reserved.
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Lepner demonstrated that EBVSS ensures a signiﬁcantly shorter
operating time for thyroidectomy (an average saving of 26 min,
p < 0.0001) and also postoperative transient hypoparathyroidism
demonstrated a signiﬁcantly lower incidence in the Ligasure group
(2.5 vs 7.0%; p ¼ 0.022).9 Authors demonstrated statistically
signiﬁcant decrease of transient postoperative hypocalcemia.10–12
Operative time, postoperative drain volume, hospital stay, and
complications were lower than in patients operated with the
conventional clamp-and-tie procedure. The device was proven
secure, effective, and rapid for legation of thyroid isthmus, middle
vein, and superior and inferior poles, in dissection of parathyroid
glands and RLN. EBVSS delivers precise amounts of energy, which
results in limited thermal spread to adjacent tissues, such as the
RLN and parathyroid glands. Experimental histologic studies of
vessels sealed with EBVSS demonstrated a mean of 1.1 mm thermal
spread, beyond the tissue within the forceps’ jaws.13–16 Barbaros
evaluated the efﬁcacy of the use of Ligasure in patients with
hyperthyroidism.17 The durations of the operation time and of the
hospital stay in the Ligasure group were signiﬁcantly lower than
the conventional thyroidectomy group. The complication rates of
the Ligasure and conventional thyroidectomy groups were 4 and
6%, respectively.17
3. Modern anesthetic technique
3.1. Regional anesthesia
It is possible to perform thyroidectomy under bilateral deep
and/or superﬁcial cervical plexus blocks.18 Regional (local) anes-
thesia is a useful alternative for speciﬁc circumstances, for example,
in mini-invasive thyroidectomy performed under superﬁcial
cervical plexus block (mono or bilateral).19 Cervical epidural anes-
thesia is another technique to perform thyroidectomy. Cervical
epidural anesthesia (CEA) results in an effective sensory blockade of
the superﬁcial cervical (C1/C4) and brachial plexus (C5/T1–T2).18,19
The potential speciﬁc complication, mainly cardiovascular and
respiratory, is the exacerbation of the effects of CEA. Side effects
such as bradycardia, hypotension and acute ventilatory failure
related to respiratory muscle paralysis, may be observed.18,19 Close
monitoring of hemodynamics, respiratory rate and level blockade is
required.18,19
3.2. General anesthesia
Intravenous anesthesia and total intravenous anesthesia (TIVA)
as well, are ﬁrmly established to an increasing degree in modern
anesthetic techniques in thyroid surgery.20 Propofol is the best
suited intravenous agent for maintenance of anesthesia: it provides
a rapid onset of anesthesia, as shown by its short t 1/2 ke0 and rapid
recovery ideal for a short hospitalization, as shown by its short
context-sensitive half-time.20 In addition, propofol has several
advantages over volatile anesthetics, for example, a very low inci-
dence of postoperative nausea and vomiting and it can be used
safely in patients susceptible to malignant hyperthermia.21 Several
newdrug delivery systems have been developed and introduced for
intravenous anesthesia in thyroid surgery. An intravenous admin-
istration system is now available, and it is called target-controlled
infusion (TCI). TCI is a computer-assisted administration of propofol
for induction and maintenance of general anesthesia.21 TCI-devices
enable the drug concentration in the blood or plasma to be
controlled continuously. They also allow administration of intra-
venous anesthetics according to their pharmacokinetic proﬁleswithout the need for complex calculations by the anesthetist. The
pharmacokinetic program of a TCI-device continuously calculates
the distribution and elimination of the intravenous anesthetic
agent, and successively adjusts the infusion rate to maintain a pre-
dicted blood or plasma drug concentration. Of all possible combi-
nations, propofol and alfentanil have the most suitable
pharmacokinetic and pharmacodynamic proﬁles for administration
by continuous infusion.20,21
4. Improvement of perioperative life quality: mini-invasive,
video-assisted, fully endoscopic thyroidectomy
Evidence-based data have emphasized the beneﬁts of endo-
scopic thyroidectomy.22–26 Different minimal invasive techniques
have been increasingly reported: fully endoscopic, videoscopic
assisted, and focused using mini-incision.22–26 In 1998, Miccoli27
developed a technique of minimally invasive video-assisted
thyroidectomy (MIVAT), a completely gasless procedure, by using
the same access already described for parathyroidectomy. Tradi-
tionally, open thyroidectomy require a 6– 8 cm, or bigger, trans-
verse wound on the lower neck while Miccoli’s approach is very
small in wound length.27 Pain following the MIVAT is much less
when compared with the conventional thyroidectomy, because
there is less dissection, traction and destruction of tissues.27 Up to
now Miccoli’s technique is the mini-invasive thyroid procedure
more widely used in operating room.1 Miccoli’s approach, in
selected patients, clearly demonstrates excellent results regarding
safety, morbidity, mortality, patient cure rate and comfort, with
short hospital stay, few postoperative pain and excellent cosmetic
results in a critical area such as the neck which cannot be under-
estimated particularly in women.1,22–27 The other mini-invasive
thyroid procedures proposed not always mean less invasiveness
because some of these operations need a longer operative time and
hospital stay.22 The small operative space, the possible trouble
linked with long insufﬂations, the endoscopic instrumentation
inadequate, as for size and design, to operate on the neck, appeared
to constitute important obstacles to the diffusion of these other
minimally invasive thyroidectomy.22
5. Prevention of postoperative laryngeal nerve
paralysis: neuromonitoring
Technical advances currently allow accurate, non-invasive RLN
monitoring during thyroidectomy.28 RLN monitoring has speciﬁc
functions: (1) to facilitate initial neural identiﬁcation; and (2) to aid
in neural dissection.28–30 RLN monitoring’s main function is that of
intraoperative prediction of postoperative function. Blunt and
stretch injury to the nervemaynot always be visibly detectable.31–33
The predictive ability of neural testing is extremely important in
bilateral thyroid surgery, because both nerves governing the
laryngeal airway are placed at riskwith one surgery. Caldarelli notes
that RLN injury during thyroidectomy may be caused by stretch/
traction, pressure, crush, electrical injury, ligature, ischemia, or
suction injury without transaction.31 In these cases the injured
nerve may, to the surgeon’s eye, appear intact. Several studies have
shown how poor the surgeon is at judging RLN injury intra-
operatively. Patlow found that in only one of 10 cases of RLN injury
were surgeons aware of the injury.32 Holt has also noted that visu-
alization and preservation of the RLN does not guarantee against
postoperative vocal cord paralysis.34
Certainly, cases that can be recognized preoperatively as likely
having greater risk to the RLN should be monitored. These cases
include: (1) cases of malignancy; (2) thyroid surgery accompanied
by signiﬁcant lymph node resection; (3) surgery for Graves’ disease
and thyroiditis; (4) surgery for substernal goiter; (5) revision
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Because numerous studies have shown that routine exposure of the
RLN is associated with lower rates of injury, RLN monitoring
represents an adjunct to, and extension of, routine visual identiﬁ-
cation of the nerve during surgery.28–30
6. Intact parathyroid hormone (iPTH) to predict
postoperative symptomatic hypocalcemia
Identifying patients with risk of hypocalcemia may facilitate
early discharge (24-h stay).35 The detection of postoperative
hypoparathyroidism has traditionally been by the serial measure-
ment of corrected serum calcium concentrations and requires
multiple venepunctures and potentially several days of hospitali-
zation after thyroidectomy. There has been much interest work
about the use of intact parathyroid hormone to better predict
hypocalcemia after thyroidectomy.36 Early iPTH perioperative
measurement in thyroid surgery is value in prediction of post-
operative symptomatic hypocalcemia, in guiding the surgeon for
parathyroid autotransplatation, in selecting of patients requiring
onset of calcium substitution and safe discharge home.37 Studies
reveled that normal postoperative PTH levels accurately predict
normocalcemia after total or complete thyroidectomy. Identiﬁca-
tion of at-risk patients with postoperative PTH levels below normal
range will facilitate prompt calcium replacement therapy and
potential safe early discharge from hospital.37 Wong found that the
combination of immediate postoperation PTH levels (<1.5 pmol/l)
and morning serum calcium (<2.0 mmol/l) could accurately iden-
tify patients at risk of hypocalcemia following total thyroidectomy,
allowing safe, early discharge.37 Lindblom found that PTH levels
after thyroidectomy were lower among patients who developed
biochemical (p < 0.001) and symptomatic hypocalcemia (p < 0.01)
compared with those who did not.38
7. Conclusion
The availability of new technology in thyroid surgery broadens
opportunities for improved operative techniques and outcomes.
But new technology has developed faster than the profession’s
ability to provide evidence-based data before widespread accep-
tance and application.39 The American College of Surgeons
addressed in its statement on Emerging Surgical Technologies, ‘‘ it is
equally essential that the value and safety of a new procedure be
established before it is widely used on patients’’.40 The impact of these
modern technologies on quality of thyroid surgery in an ambula-
tory setting is remarkable for:
 Prevention of bleeding with new devices for the hemostasis
and dissection.
 Prevention of laryngeal nerve paralysis with intraoperative
neuromonitoring.
 Reduction of postoperative symptomatic hypocalcemia with
early iPTH measurement.
 Improvement of perioperative life quality by minimally inva-
sive procedures.
These new modalities aim to improve quality of thyroid surgery
with safety of treatment and early discharge.41 No reports have
deﬁned any increase in the morbidity rates due to the use of these
new devices. Speciﬁc experience and training with these new
devices are essential for optimal use. The devices require a senior
Endocrine Surgeon with a high level of experience when used,
because they can easily injure surrounding vital structures. More-
over, surgeon volume and experience correlates with improved
outcomes for complex operations.42 New technologies duringthyroidectomy may be easily organized in Centers of endocrine
surgery. However, most patients with thyroid problems are still
treated in smaller surgical units. Therefore, modern devices may be
a logistical problem. Moreover, good results are achieved by perfect
and planned interdisciplinary collaboration. An efﬁcient structural
organization is necessary to control postoperative complications.
An organized and methodical approach with modern surgical
techniques will shift towards more one-day-surgery with more
patient-centered care which is the priority in health care today.35Conﬂict of interest
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